Nakanishi, Shuhei http://orcid.org/0000-0003-2640-9632
Hirukawa, Hidenori
Shimoda, Masashi
Tatsumi, Fuminori
Kohara, Kenji
Obata, Atsushi
Okauchi, Seizo
Kinoshita, Tomoe
Sanada, Junpei
Fushimi, Yoshiro
Nishioka, Momoyo
Kan, Yuki
Tomita, Akiko
Mashiko, Akiko
Horiya, Megumi
Iwamoto, Yuichiro
Mune, Tomoatsu
Kaku, Kohei
Kaneto, Hideaki
Article History
Received: 29 November 2018
Accepted: 23 January 2019
First Online: 31 January 2019
Competing interest
: Hideaki Kaneto has received honoraria for lectures and received scholarship grants from Sanofi, Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Taisho Toyama Pharma, MSD, Takeda, Ono Pharma, Daiichi Sankyo, Sumitomo Dainippon Pharma, Mitsubishi Tanabe Pharma, Kissei Pharma, Astellas, Novartis, Kowa, Chugai, the Japan Foundation for Applied Enzymology, and A2 Healthcare. Kohei Kaku has been an advisor to, received honoraria for lectures from, and received scholarship grants from Novo Nordisk Pharma, Sanwa Kagaku Kenkyusho, Takeda, Taisho Pharmaceutical Co., MSD, Taisho Toyama Pharma., Astellas, Kissei Pharma., Mitsubishi Tanabe Pharma. Co., Ono Pharma. Co., Sumitomo Dainippon Pharma, Novartis, Mitsubishi Tanabe Pharma, AstraZeneca, Nippon Boehringer Ingelheim Co., Fujifilm Pharma Co., and Sanofi. M.S. and S.N. have received honoraria for lectures from AstraZeneca and Sanofi, respectively.
: The hospital ethics committee approved the study protocol, and information on the study was provided to the public via the Internet, in place of obtaining informed consent from each patient (No. 3115).
: Not applicable.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.